ACW 13.0% 8.7¢ actinogen medical limited

Under valued stock, page-162

  1. 6,434 Posts.
    lightbulb Created with Sketch. 5274
    Thanks Davi,

    A very insightful article & very helpful. I don’t believe that the FDA will lower standards as I have said in previous posts, the biomarker & PET scan standards are interesting, as is an approved drug to run combo trials with (Tau, Cortisol inhibition, neuroinflammatory) quite a bit of discussion there regarding combo therapy.

    I do believe that Xanamem will be most helpful in early AD, & what we call ‘healthy older adults’ & early AD, grey line there until biomarkers.

    Back to the ‘grind’ today, still awaiting dinner to cook for the family, thanks again @Davisite.
 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
(20min delay)
Last
8.7¢
Change
0.010(13.0%)
Mkt cap ! $234.4M
Open High Low Value Volume
7.9¢ 8.7¢ 7.8¢ $1.341M 16.31M

Buyers (Bids)

No. Vol. Price($)
1 11627 8.6¢
 

Sellers (Offers)

Price($) Vol. No.
8.7¢ 663394 5
View Market Depth
Last trade - 16.10pm 17/07/2024 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.